HEALTH● LOWJun 26 · Jun 26, 2026, 6:40 PM
China Approves CARsgen’s CAR-T Treatment for Stomach Cancer
Human Progress
“China’s drug regulator said on Monday it has approved a CARsgen Therapeutics treatment for stomach cancer, a new milestone for CAR-T therapies, which engineer patients’ immune cells to recognise and kill cancer cells. The injection, also known as satri-cel, is globally the first approved CAR-T cell therapy for solid tumors, CARsgen CEO Li Zonghai told […] The post China Approves CARsgen’s CAR-T Treatment for Stomach Cancer appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH33m agoWhite House chief of staff Susie Wiles had medical procedure at Mayo ClinicCBS NewsHEALTHBREAKING48m agoOne dead as Taraba records first diphtheria caseVanguard NigeriaHEALTH1h agoShe is 34 years old and received chemotherapy by mistake for more than a decade: "It ruined my life"ClarínHEALTHBREAKING1h agoTaraba Records First Confirmed Diphtheria Case, Patient DiesChannels TV